All

What are you looking for?

All
Projects
Results
Organizations

Quick search

  • Projects supported by TA ČR
  • Excellent projects
  • Projects with the highest public support
  • Current projects

Smart search

  • That is how I find a specific +word
  • That is how I leave the -word out of the results
  • “That is how I can find the whole phrase”

An integrated microfluidic platform for nucleic acid testing

The result's identifiers

  • Result code in IS VaVaI

    <a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216305%3A26220%2F24%3APU151385" target="_blank" >RIV/00216305:26220/24:PU151385 - isvavai.cz</a>

  • Alternative codes found

    RIV/62156489:43210/24:43925295

  • Result on the web

    <a href="https://www.nature.com/articles/s41378-024-00677-6" target="_blank" >https://www.nature.com/articles/s41378-024-00677-6</a>

  • DOI - Digital Object Identifier

    <a href="http://dx.doi.org/10.1038/s41378-024-00677-6" target="_blank" >10.1038/s41378-024-00677-6</a>

Alternative languages

  • Result language

    angličtina

  • Original language name

    An integrated microfluidic platform for nucleic acid testing

  • Original language description

    This study presents a rapid and versatile low-cost sample-to-answer system for SARS-CoV-2 diagnostics. The system integrates the extraction and purification of nucleic acids, followed by amplification via either reverse transcription-quantitative polymerase chain reaction (RT–qPCR) or reverse transcription loop-mediated isothermal amplification (RT–LAMP). By meeting diverse diagnostic and reagent needs, the platform yields testing results that closely align with those of commercial RT-LAMP and RT‒qPCR systems. Notable advantages of our system include its speed and cost-effectiveness. The assay is completed within 28 min, including sample loading (5 min), ribonucleic acid (RNA) extraction (3 min), and RT-LAMP (20 min). The cost of each assay is ≈ $9.5, and this pricing is competitive against that of Food and Drug Administration (FDA)-approved commercial alternatives. Although some RNA loss during on-chip extraction is observed, the platform maintains a potential limit of detection lower than 297 copies. Portability makes the system particularly useful in environments where centralized laboratories are either unavailable or inconveniently located. Another key feature is the platform’s versatility, allowing users to choose between RT‒qPCR or RT‒LAMP tests based on specific requirements.

  • Czech name

  • Czech description

Classification

  • Type

    J<sub>imp</sub> - Article in a specialist periodical, which is included in the Web of Science database

  • CEP classification

  • OECD FORD branch

    20602 - Medical laboratory technology (including laboratory samples analysis; diagnostic technologies) (Biomaterials to be 2.9 [physical characteristics of living material as related to medical implants, devices, sensors])

Result continuities

  • Project

    <a href="/en/project/VI04000057" target="_blank" >VI04000057: An ultrafast portable system to detect SARS-CoV-2</a><br>

  • Continuities

    P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)

Others

  • Publication year

    2024

  • Confidentiality

    S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Data specific for result type

  • Name of the periodical

    Microsystems & Nanoengineering

  • ISSN

    2055-7434

  • e-ISSN

  • Volume of the periodical

    10

  • Issue of the periodical within the volume

    1

  • Country of publishing house

    CN - CHINA

  • Number of pages

    14

  • Pages from-to

    1-14

  • UT code for WoS article

    001229356700001

  • EID of the result in the Scopus database